Mark Hulett
La Trobe University, VIC, Australia
- This delegate is presenting an abstract at this event.
Prof Hulett completed his doctoral studies in 1994 at The University of Melbourne in on immune cell receptors in inflammation and allergy. He was awarded an NHMRC Fellowship (1995-1998) to continue his work on immune receptors at the Austin Research Institute. Prof Hulett moved to The Australian National University in 1999 where he cloned the heparan sulphate-degrading enzyme heparanase and described its important role in inflammatory disease and cancer. Following the awarding of a Viertel Senior Medical Research Fellowship in 2002, Prof Hulett established an independent laboratory at ANU to study molecular aspects of immune and tumour cell migration. In 2008 Prof Hulett moved his research group to the Department of Biochemistry at La Trobe University (LTU). His current research interests include inflammation and the tumour microenvironment, as well as the mechanisms of action and therapeutic application of host defense peptides. He has published over 150 peer-reviewed papers with 10,000+ citations, as well being lead inventor on 6 patents. Prof Hulett is the current Head of Department of Biochemistry and Chemistry at La Trobe University (2019-) and has previously held the positions of Research Director (2015-2016) and Deputy Director (2017-2019) of the La Trobe Institute for Molecular Science at LTU.
Presentations this author is a contributor to:
Defensin-lipid interactions in membrane targeting: novel insights into mechanisms of action and therapeutic potential (#60)
11:40 AM
Mark D Hulett
SESSION 11: Antiinfectives